https://scholars.lib.ntu.edu.tw/handle/123456789/593940
標題: | Safety of baricitinib in East Asian patients with moderate-to-severe active rheumatoid arthritis: An integrated analysis from clinical trials | 作者: | Chen, Ying-Chou Yoo, Dae Hyun Lee, Chang Keun KO-JEN LI Won, Ji-Eon Wu, Wen-Shuo Zhong, Jinglin Nicolay, Claudia Walls, Chad Daniel Tanaka, Yoshiya |
關鍵字: | East Asia; Janus kinase (JAK); baricitinib; clinical studies; rheumatoid arthritis; safety | 公開日期: | 一月-2020 | 出版社: | WILEY | 卷: | 23 | 期: | 1 | 起(迄)頁: | 65 | 來源出版物: | International journal of rheumatic diseases | 摘要: | We evaluated the safety of baricitinib in an East Asian (EA) patient population with moderate-to-severely active rheumatoid arthritis (RA), through an integrated sub-analysis of data from the overall baricitinib RA clinical program. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/593940 | ISSN: | 1756-1841 | DOI: | 10.1111/1756-185X.13748 | SDG/關鍵字: | baricitinib; azetidine derivative; baricitinib; sulfonamide; acute pyelonephritis; adult; aged; Article; B cell lymphoma; benign neoplasm; cardiovascular disease; cerebrovascular accident; Chinese; controlled study; deep vein thrombosis; digestive system perforation; drug efficacy; drug safety; drug tolerability; drug withdrawal; East Asian; esophagus candidiasis; female; heart infarction; hematologic disease; hepatobiliary disease; herpes zoster; human; incidence; infection; Japanese (people); Korean (people); lymphatic system disease; lymphoproliferative disease; major clinical study; male; malignant neoplasm; mediastinum disease; opportunistic infection; Pneumocystis pneumonia; pneumonia; post hoc analysis; priority journal; respiratory tract disease; rheumatoid arthritis; rhinopharyngitis; Taiwanese; thorax disease; tuberculosis; upper respiratory tract infection; clinical trial; dose response; follow up; middle aged; multicenter study; phase 2 clinical trial; phase 3 clinical trial; randomized controlled trial; rheumatoid arthritis; South Korea; time factor; treatment outcome; Arthritis, Rheumatoid; Azetidines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Republic of Korea; Sulfonamides; Time Factors; Treatment Outcome |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。